Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Truex Insider Profile

4 Followers

Paul Truex, Director at Milestone Pharmaceuticals, holds 81.78K shares in Milestone Pharmaceuticals (Ticker: MIST), holds 101.84K shares in Anthera Pharmaceuticals (Ticker: ANTH), holds ― shares in CymaBay Therapeutics (Ticker: CBAY).

Paul Truex's Trading History

MIST
Milestone Pharmaceuticals
Jun 01, 2022DirectorUninformative Buy115.80K$29.85K
ANTH
Anthera Pharmaceuticals
Sep 07, 2017DirectorInformative Buy6.70K―
TSRX
Trius Therap
Aug 02, 2010―Uninformative Buy――
CBAY
CymaBay Therapeutics
――――

You May Also Like

Paul Truex insider profile FAQ

What is the percentage of profitable transactions made by Paul Truex?
The percentage of profitable transactions made by Paul Truex is 33%.
What is the average return per transaction made by Paul Truex?
The average return per transaction made by Paul Truex is 7.70%.
What stocks does Paul Truex hold?
Paul Truex holds: MIST, ANTH, CBAY, TSRX stocks.
What was Paul Truex’s latest transaction?
Paul Truex’s latest transaction was an Uninformative Buy of $115.80K.
What was Paul Truex's most profitable transaction?
Paul Truex’s most profitable transaction was an Informative Buy of ANTH stock on July 1, 2014. The return on the trade was 149.10%.
What is Paul Truex's role in Milestone Pharmaceuticals?
Paul Truex's role in Milestone Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.